The validity of peak inspiratory mouth pressure (P.PImax) as a measure of inspiratory muscle strength was investigated by comparing it with sniff Pes in patients with COPD with respect to (1) learning effect, (2) reproducibility, and (3) In the present study, we investigated whether instantaneous peak inspiratory mouth pressure during a maximal static maneuver (P.Plmax) is a valid assessment of inspiratory muscle strength. Especially in patients with respiratory failure, only P.PImax can be measured during a maximal static maneuver, because these patients cannot sustain their pressure.8'9
The validity of peak inspiratory mouth pressure (P.PImax) as a measure of inspiratory muscle strength was investigated by comparing it with sniff Pes in patients with COPD with respect to (1) learning effect, (2) reproducibility, and (3) measures of agreement. To assess the discriminating capacity of P.Plmax, we compared the values in patients with COPD with those of healthy elderly subjects. Thirty-four patients (mean age, 62.5 years) with severe airways obstruction (FEV1, 44%0 predicted; FEV1/IVC, 37% predicted) and 149 healthy subjects (age -55 years) were included. P.PImax was assessed during a maximal static inspiratory maneuver, while sniff Pes was assessed during a maximal sniff maneuver. Both maneuvers were performed from residual volume ten times on the same day. P.PImax showed no learning effect, while the sniff maneuver used seven attempts to obtain a maximal value. The intraindividual coefficients of variation of P.Plmax and sniff Pes were Conventionally, inspiratory muscle strength has been assessed by maximal inspiratory mouth pressure sustained for 1 s (Plmax) during a maximal static maneuver against a closed shutter.'15 However, Plmax is poorly reproducible with an average coefficient of variation of 25% 6 Furthermore, Smyth et a17 showed substantial and significant variations in reported normal values for Plmax.
In the present study, we investigated whether instantaneous peak inspiratory mouth pressure during a maximal static maneuver (P.Plmax) is a valid assessment of inspiratory muscle strength. Especially in patients with respiratory failure, only P.PImax can be measured during a maximal static maneuver, because these patients cannot sustain their pressure.8 '9 We compared P.PImax with the sniff maneuver, during which pressure can be measured at the mouth (Pmo),10 in the esophagus (Pes),'0 and across the di- The aim of our study was to investigate whether the noninvasive P.PImax is a valid assessment of inspiratory muscle strength by comparing it with sniff Pes in patients with COPD with respect to (1) learning effect (defined as the number of attempts needed to achieve the maximal value), (2) reproducibility, and (3) measures of agreement. Furthermore, to assess the discriminating capacity of peak inspiratory mouth pressure, we compared P.Plmax in a group of patients with COPD with P.PImax in a group of healthy elderly subjects, comparable for age and gender. The latter group was aselectively drawn from a large population of healthy elderly subjects. rehabilitation program. All patients were in a clinical stable condition with optimal drug management. Entry criteria were (1) FEV, <60% predicted and (2) FEV,/IVC (inspiratory vital capacity) <50% both after bronchodilation with two inhalations of 40 ,ug of ipratropium bromide. The study was approved by the medical ethics committee of the University Hospital of Groningen and all patients gave informed consent.
METHODS

Healthy Subjects
We studied 248 subjects (121 male and 127 female subjects) aged >-55 years. Subjects were randomly drawn from a sample of the general population of the province of Drenthe in the Netherlands, and they participated in a larger investigation regarding the health status of elderly subjects. A healthy subject was defined in our study according to the following functional criteria: FEV, ( by FEV, and IVC, while inspiratory muscle strength was assessed by peak inspiratory mouth pressure (P.Plmax).
Static lung volumes were determined in a constant-volume whole-body plethysmograph (Jaeger, Wiirzburg, Germany). Spirometry was performed by a pneumotachograph (Jaeger) in patients with COPD, and by a water-sealed spirometer (Lode, Groningen, the Netherlands) in healthy subjects. Transfer factor for carbon monoxide (TLCO) was measured by the single breath method. Volume/pressure (V-P) diagrams of the lungs were recorded using an esophageal balloon. Static compliance was calculated from the V/P diagram.
P.Plmax was measured by a pressure transducer (Hewlett Packard GmbH, 782018, Homburg, Germany). All patients were seated, wore a noseclip, and carried out their maximal inspiratory maneuvers from residual volume (RV). They performed against a closed shutter through an oval flanged mouthpiece with a leak of 2.0 mm diameter to prevent using the buccinator muscles.
Sniff Pes was assessed by using a 10-cm balloon, containing 0.5 mL of air and positioned in the middle of the esophagus, 40 cm from the anterior nares. The balloon was connected to a pressure transducer (Hewlett Packard GmbH, 782018, Homburg, Germany). All patients were seated and the esophageal pressure was measured during a maximal sniff (short sharp sniff as hard as possible) with the mouth closed from RV.12 Both P.Plmax and sniff Pes were carried out ten times in patients with COPD, while P.Plmax was assessed five times in healthy subjects. There was at least 20 to 30 s rest between each measurement and all assessments were recorded. In all sessions, the display in front of the patient provided visual feedback. None of the patients and healthy subjects had previously performed these inspiratory maneuvers. Before each measurement, the pressure transducer was calibrated with a reference instrument (Gambro K07046, Gambro AB, Lund, Sweden) and ambient pressure was used as zero level.
Statistical Analysis
Learning effects of both P. 
Quantitative relationship between P.Plmax and sniff Pes was assessed with measures of agreement described by Bland and Altman. 15 The strength of the relation between P.Plmax and sniff Pes was assessed by Pearson's correlation coefficient (r). The mean difference between P.Plmax and sniff Pes in the patients with COPD was determined with the paired Student's t test. The mean difference between P.Plmax in healthy subjects and P.Plmax in patients with COPD was determined by the unpaired Students's t test. Significance level was set at 5%. Kolmogorov-Smirnov (K-S) test was used to investigate whether the variables showed a normal distribution.
RESULTS
All variables showed no deviation from a normal distribution.
Patients With COPD Table 1 presents the characteristics of 34 patients with COPD. All had severe airflow limitation (mean FEV1, 44% of predicted; mean FEV1/VC, 37%). P.Plmax and sniff Pes were 8.0±2.5 kPa (mean + SD) and 8.3 ± 1.9 kPa, respectively.
Learning Effects and Intraindividual Variation
The intraindividual variability of P.Plmax and sniff Pes, expressed as coefficient of variation, in patients with COPD was 11.2% and 6.0%, respectively. Assessments of learning effects in P.Plmax and sniff Pes are shown in Figure 1 . There was a significant difference between the first and highest (ninth) attempt (average difference being 1.74 kPa, p<0.001) of the sniff Pes. From the seventh measurement onward, there was no significant difference (<5% increase, p>0.05). None of the attempts of P.Plmax showed significant differences with the highest (fourth) attempt. We screened 248 subjects (121 male and 127 female subjects). Forty-nine male subjects (40%) and 50 female subjects (39%) were excluded because of low FEV1 and/or FEV,/IVC. Therefore, 72 male and 77 female healthy subjects (Table 1) took part in the assessment of reference values of P.Plmax. P.PImax was significantly (p<0.01) higher in the male subjects aged .64 years compared with both older DISCUSSION This study shows that P.PImax had no learning effect, an acceptable intraindividual variation, and an acceptable agreement with sniff Pes in patients with COPD. Furthermore, the P.PImax in healthy subjects is significantly higher than P.Plmax in patients with COPD of comparable age and gender.
As for the learning effect, patients with COPD needed only two attempts to achieve their maximal P.Plmax, while seven attempts are needed for the sniff maneuver. This indicates that patients learn the P.Plmax maneuver more easily than the sniff maneuver. The learning effect of P.Plmax is in accordance with the observed three necessary attempts to obtain Plmax in COPD in the study of Larson et al, '6 who use also a flanged mouthpiece. In contrast with the latter study, it was shown that Plmax in patients with COPD showed a plateau after nine attempts.17
However, a good comparison among the three studies is not possible, because we measured P.PImax while the other two studies measure Plmax.16,17 Furthermore, Fiz et al17 did not mention the type of mouthpiece they used, which may influence Plmax values.
The intraindividual coefficient of variation (CV) of P.PImax (11.2%) was higher than sniff Pes (6.0%). Both CVs are comparable with two other studies investigating inspiratory muscle strength.2'12 Wilson et a12 showed that the CV of Plmax is 10.2%, assessed in five healthy subjects for 5 days. In the study of Miller et al,12 the within-subject variation was assessed three times on three occasions for three consecutive days in eight healthy subjects. They found that the transdiaphragmatic pressure (Pdi) during a Plmax method was more variable (CV = 13%) than Pdi during a sniff (CV=7.2%). Since it may be expected that the CV in COPD is generally larger, we conclude that P.PImax has an acceptable intraindividual CV.
We found an acceptable agreement between P.PImax with sniff Pes (Fig 2) . As far as we know, only Heritier et 20 Assuming that these influences are also valid for P.Plmax, we assessed P.PImax in healthy elderly subjects and stratified our patients for age and gender. We found that P.PImax is lower in female subjects compared with male subjects and that P.Plmax decreases with age. This is in agreement with studies investigating Plmaxl-5 instead of P.PImax.
Because of the influence of age and gender on P.Plmax, we compared P.Plmax in patients with COPD with P.Plmax in healthy subjects of comparable age and gender. We found a significantly lower P.Plmax in patients with COPD, being 73% of the control group, although there is a considerable overlap between healthy subjects and patients with COPD when P.Plmax is below 11.0 kPa. A P.Plmax higher than 11 kPa occurred in 19 healthy subjects and only 2 patients with COPD. We believe that a P.Plmax of at least 11.0 kPa can be considered as normal inspiratory muscle strength, while a P.Plmax lower than 11.0 kPa may indicate weak inspiratory muscle strength. Morrison et al2' found a significantly lower Plmax in patients with COPD compared with healthy subjects of the same age, being 64% predicted. This is comparable with another study22 finding a Plmax in patients with COPD of 56% predicted. The difference between our study and the other studies21'22 may be due to a lower degree of hyperinflation in our patients. Previous investigations showed that Plmax decreases with higher TLC expressed as percent predicted.22 However, the less favorable position of the diaphragm in patients with COPD compared with healthy persons is not the only reason for an impaired inspiratory muscle strength in patients with COPD. Rochester and Braun22 showed that generalized muscle weakness in patients with COPD contributes to a low inspiratory muscle strength next to hyperinflation.
Our study shows that P.Plmax is a valid method to assess inspiratory muscle strength. Moreover, P.PImax is a noninvasive method and it takes less time to obtain a maximum value compared with the sniff maneuver. These results support the clinical utility of P.Plmax to assess inspiratory muscle strength in two different circumstances. On the one hand, P.PImax can be easily measured during routine follow-up of ambulant patients with COPD. On the other hand, P.Plmax is a good method to assess inspiratory muscle strength in patients with respiratory failure who cannot undergo an invasive assessment of inspiratory muscle strength due to respiratory distress. 
